| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Tablin-Wolf Alex | SVP, GC and Corp. Secretary | 1050 CONSTITUTION AVENUE, PHILADELPHIA | /s/ Mark Sherman, attorney-in-fact | 29 Dec 2025 | 0002003204 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXTA | Common Shares | Options Exercise | +1,888 | +11% | 19,612 | 23 Dec 2025 | Direct | F1 | ||
| transaction | AXTA | Common Shares | Tax liability | $28,180 | -873 | -4.5% | $32.28 | 18,739 | 23 Dec 2025 | Direct | F2 |
| transaction | AXTA | Common Shares | Options Exercise | +3,284 | +18% | 22,023 | 23 Dec 2025 | Direct | F1 | ||
| transaction | AXTA | Common Shares | Tax liability | $49,033 | -1,519 | -6.9% | $32.28 | 20,504 | 23 Dec 2025 | Direct | F2 |
| transaction | AXTA | Common Shares | Options Exercise | +3,500 | +17% | 24,004 | 23 Dec 2025 | Direct | F1 | ||
| transaction | AXTA | Common Shares | Tax liability | $52,261 | -1,619 | -6.7% | $32.28 | 22,385 | 23 Dec 2025 | Direct | F2 |
| transaction | AXTA | Common Shares | Options Exercise | +1,353 | +6% | 23,738 | 23 Dec 2025 | Direct | F1 | ||
| transaction | AXTA | Common Shares | Tax liability | $20,207 | -626 | -2.6% | $32.28 | 23,112 | 23 Dec 2025 | Direct | F2 |
| transaction | AXTA | Common Shares | Options Exercise | +471 | +2% | 23,583 | 23 Dec 2025 | Direct | F1 | ||
| transaction | AXTA | Common Shares | Tax liability | $7,037 | -218 | -0.92% | $32.28 | 23,365 | 23 Dec 2025 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXTA | Restricted Stock Units | Options Exercise | $0 | -1,888 | -100% | $0.000000 | 0 | 23 Dec 2025 | Common Shares | 1,888 | Direct | F1, F3, F8 | |
| transaction | AXTA | Restricted Stock Units | Options Exercise | $0 | -3,284 | -50% | $0.000000 | 3,284 | 23 Dec 2025 | Common Shares | 3,284 | Direct | F1, F4, F8 | |
| transaction | AXTA | Restricted Stock Units | Options Exercise | $0 | -3,500 | -33% | $0.000000 | 7,000 | 23 Dec 2025 | Common Shares | 3,500 | Direct | F1, F5, F8 | |
| transaction | AXTA | Performance Share Units | Options Exercise | $0 | -1,353 | -100% | $0.000000 | 0 | 23 Dec 2025 | Common Shares | 1,353 | Direct | F1, F6, F8 | |
| transaction | AXTA | Performance Share Units | Options Exercise | $0 | -471 | -100% | $0.000000 | 0 | 23 Dec 2025 | Common Shares | 471 | Direct | F1, F7, F8 |
| Id | Content |
|---|---|
| F1 | Restricted stock units and performance share units each convert into common shares on a one-for-one basis. |
| F2 | Shares withheld to satisfy the tax withholding obligation applicable to the vesting of a portion of a restricted stock unit award or a performance share unit award, as applicable. |
| F3 | On February 28, 2023, the reporting person was granted 5,664 restricted stock units vesting in three equal annual installments beginning on February 28, 2024, but the vesting of the portion reflected herein was accelerated from February 28, 2026 in order to mitigate the potential adverse impact to the Company and the reporting person of Section 280G of the Internal Revenue Code in connection with the pending transaction between the Company and Akzo Nobel N.V. (the "Section 280G Mitigation"). |
| F4 | On February 28, 2024, the reporting person was granted 9,852 restricted stock units vesting in three equal annual installments beginning on February 28, 2025, but the vesting of the portion reflected herein was accelerated from February 28, 2026, in connection with the Section 280G Mitigation. |
| F5 | On March 4, 2025, the reporting person was granted 10,500 restricted stock units vesting in three equal annual installments beginning on March 4, 2026, but the vesting of the portion reflected herein was accelerated from March 4, 2026, in connection with the Section 280G Mitigation. |
| F6 | Represents the partial vesting of a performance share unit award granted on February 28, 2023. The number of common shares issuable under the award may range from zero to 200% of the target number of performance share units (943) based upon the Company's achievement of Adjusted EBITDA during the relevant performance period as described in more detail in the Company's proxy statement filed with the SEC on April 24, 2024. The partial vesting reflected herein was accelerated from 2026 in connection with the Section 280G Mitigation based on an estimate of actual performance. The vesting will remain subject to a true-up once actual performance is determined. |
| F7 | Represents the partial vesting of a performance share unit award granted on February 28, 2023. The number of common shares issuable under the award may range from zero to 200% of the target number of performance share units (943) based upon the Company's achievement of relative total shareholder return during the relevant performance period as described in more detail in the Company's proxy statement filed with the SEC on April 24, 2024. The partial vesting reflected herein was accelerated from 2026 in connection with the Section 280G Mitigation based on an estimate of actual performance. The vesting will remain subject to a true-up once actual performance is determined. |
| F8 | This vesting will be subject to clawback in the event it is determined that the reporting person would not have ultimately vested in the award, notwithstanding the acceleration reflected herein. |